Source: Supportive care in cancer. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, MIOSITE, ESTUDOS RANDOMIZADOS
ABNT
KAUARK-FONTES, Elisa et al. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, v. 30, n. 3, p. 2225-2236, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00520-021-06625-8. Acesso em: 06 nov. 2024.APA
Kauark-Fontes, E., Migliorati, C. A., Epstein, J. B., Treister, N. S., Alves, C. G. B., Faria, K. M., et al. (2022). Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, 30( 3), 2225-2236. doi:10.1007/s00520-021-06625-8NLM
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-021-06625-8Vancouver
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00520-021-06625-8